Advanced search
Publication Cover
OncoImmunology Volume 11, 2022 - Issue 1
Submit an article Journal homepage
2,191
Views
1
CrossRef citations to date
0
Altmetric
Brief Report

Reprogramming monocyte-derived macrophages through caspase inhibition

Paul Chaintreuila INSERM U1065, C3M, Université Côte d’Azur, Nice, FranceView further author information
,
Lucie Laplaneb INSERM U1187, Gustave Roussy Cancer Center, Villejuif, France;c CNRS U8590, Institut d’Histoire et Philosophie des Sciences et des Techniques, Université Paris I Panthéon-Sorbonne, Paris, FranceView further author information
,
Florian Esnaulta INSERM U1065, C3M, Université Côte d’Azur, Nice, FranceView further author information
,
Victoria Ghesquiera INSERM U1065, C3M, Université Côte d’Azur, Nice, FranceView further author information
,
Coline Savya INSERM U1065, C3M, Université Côte d’Azur, Nice, FranceView further author information
,
Nathan Furstossa INSERM U1065, C3M, Université Côte d’Azur, Nice, FranceView further author information
,
Marie-Laure Arcangelia INSERM U1065, C3M, Université Côte d’Azur, Nice, FranceView further author information
,
Thomas Cluzeaua INSERM U1065, C3M, Université Côte d’Azur, Nice, France;d Département d’Hématologie Clinique, Chu de Nice, Nice, FranceView further author information
,
Guillaume Roberta INSERM U1065, C3M, Université Côte d’Azur, Nice, FranceView further author information
,
Nathalie Droinb INSERM U1187, Gustave Roussy Cancer Center, Villejuif, France;e Faculté de Médecine, Université Paris-Sud, Le Kremlin-Bicêtre, FranceView further author information
,
Eric Solaryb INSERM U1187, Gustave Roussy Cancer Center, Villejuif, France;e Faculté de Médecine, Université Paris-Sud, Le Kremlin-Bicêtre, FranceView further author information
,
Patrick Aubergera INSERM U1065, C3M, Université Côte d’Azur, Nice, FranceView further author information
&
Arnaud Jacquela INSERM U1065, C3M, Université Côte d’Azur, Nice, FranceCorrespondence[email protected]
View further author information
 show all
Article: 2015859 | Received 24 Sep 2021, Accepted 03 Dec 2021, Published online: 30 Dec 2021

References

  • Shapouri-Moghaddam A, Mohammadian S, Vazini H, Taghadosi M, Esmaeili SA, Mardani F, Seifi B, Mohammadi A, Afshari JT, Sahebkar A, et al. Macrophage plasticity, polarization, and function in health and disease. J Cell Physiol. 2018 Sep;233(9):6425–7. doi:10.1002/jcp.26429.
  • Bleriot C, Chakarov S, Ginhoux F. Determinants of resident tissue macrophage identity and function. Immunity. 2020 Jun 16;52(6):957–970. doi:10.1016/j.immuni.2020.05.014.
  • Zhang C, Yang M, Ericsson AC. Function of macrophages in disease: current understanding on molecular mechanisms. Front Immunol. 2021;12:620510. doi:10.3389/fimmu.2021.620510.
  • Ricketts TD, Prieto-Dominguez N, Gowda PS, Ubil E. Mechanisms of macrophage plasticity in the tumor environment: manipulating activation state to improve outcomes. Front Immunol. 2021;12:642285. doi:10.3389/fimmu.2021.642285.
  • Rebe C, Cathelin S, Launay S, Filomenko R, Prevotat L, L’Ollivier C, Gyan E, Micheau O, Grant S, Dubart-Kupperschmitt A, et al. Caspase-8 prevents sustained activation of NF-kappaB in monocytes undergoing macrophagic differentiation. Blood. 2007 Feb 15, 109(4):1442–1450. doi:10.1182/blood-2006-03-011585.
  • Jacquel A, Benikhlef N, Paggetti J, Lalaoui N, Guery L, Dufour EK, Ciudad M, Racoeur C, Micheau O, Delva L, et al. Colony-stimulating factor-1-induced oscillations in phosphatidylinositol-3 kinase/AKT are required for caspase activation in monocytes undergoing differentiation into macrophages. Blood. 2009 Oct 22, 114(17):3633–3641. doi:10.1182/blood-2009-03-208843.
  • Guery L, Benikhlef N, Gautier T, Paul C, Jego G, Dufour E, Jacquel A, Cally R, Manoury B, Vanden Berghe T, et al. Fine-tuning nucleophosmin in macrophage differentiation and activation. Blood. 2011 Oct 27, 118(17):4694–4704. doi:10.1182/blood-2011-03-341255.
  • Cathelin S, Rebe C, Haddaoui L, Simioni N, Verdier F, Fontenay M, Launay S, Mayeux P, Solary E. Identification of proteins cleaved downstream of caspase activation in monocytes undergoing macrophage differentiation. J Biol Chem. 2006 Jun 30;281(26):17779–17788. doi:10.1074/jbc.M600537200.
  • Jacquel A, Obba S, Boyer L, Dufies M, Robert G, Gounon P, Lemichez E, Luciano F, Solary E, Auberger P, et al. Autophagy is required for CSF-1-induced macrophagic differentiation and acquisition of phagocytic functions. Blood. 2012 May 10, 119(19):4527–4531. doi:10.1182/blood-2011-11-392167.
  • Obba S, Hizir Z, Boyer L, Selimoglu-Buet D, Pfeifer A, Michel G, Hamouda M-A, Gonçalvès D, Cerezo M, Marchetti S, et al. The PRKAA1/AMPKalpha1 pathway triggers autophagy during CSF1-induced human monocyte differentiation and is a potential target in CMML. Autophagy. 2015;11(7):1114–1129. doi:10.1080/15548627.2015.1034406.
  • Lee H, Shin EA, Lee JH, Ahn D, Kim CG, Kim JH, et al. Caspase inhibitors: a review of recently patented compounds (2013-2015). Expert Opin Ther Pat. 2018 Jan;28(1):47–59. doi:10.1080/13543776.2017.1378426.
  • Baskin-Bey ES, Washburn K, Feng S, Oltersdorf T, Shapiro D, Huyghe M, Burgart L, Garrity-Park M, van Vilsteren FGI, Oliver LK, et al. Clinical Trial of the Pan-Caspase Inhibitor, IDN-6556, in human liver preservation injury. Am J Transplant. 2007 Jan;7(1):218–225. doi:10.1111/j.1600-6143.2006.01595.x.
  • Chen Y, Jin H, Song Y, Huang T, Cao J, Tang Q, et al. Targeting tumor-associated macrophages: a potential treatment for solid tumors. J Cell Physiol. 2021 May;236(5):3445–3465. doi:10.1002/jcp.30139.
  • Poltavets AS, Vishnyakova PA, Elchaninov AV, Sukhikh GT, Fatkhudinov TK. Macrophage modification strategies for efficient cell therapy. Cells. 2020 Jun 24;9(6):1535. doi:10.3390/cells9061535.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.